Cargando…
Empagliflozin suppressed cardiac fibrogenesis through sodium-hydrogen exchanger inhibition and modulation of the calcium homeostasis
BACKGROUND: The novel sodium-glucose co-transporter 2 inhibitor (SGLT2i) potentially ameliorates heart failure and reduces cardiac arrhythmia. Cardiac fibrosis plays a pivotal role in the pathophysiology of HF and atrial myopathy, but the effect of SGLT2i on fibrogenesis remains to be elucidated. Th...
Autores principales: | Chung, Cheng-Chih, Lin, Yung-Kuo, Chen, Yao-Chang, Kao, Yu-Hsun, Yeh, Yung-Hsin, Trang, Nguyen Ngoc, Chen, Yi-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903522/ https://www.ncbi.nlm.nih.gov/pubmed/36747205 http://dx.doi.org/10.1186/s12933-023-01756-0 |
Ejemplares similares
-
Calcium Regulation on the Atrial Regional Difference of Collagen Production Activity in Atrial Fibrogenesis
por: Chung, Cheng-Chih, et al.
Publicado: (2021) -
Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats
por: Lee, Ting-I, et al.
Publicado: (2019) -
Regional Diversities in Fibrogenesis Weighed as a Key Determinant for Atrial Arrhythmogenesis
por: Chung, Cheng-Chih, et al.
Publicado: (2021) -
Colchicine modulates calcium homeostasis and electrical property of HL‐1 cells
por: Lu, Yen‐Yu, et al.
Publicado: (2016) -
Empagliflozin and Renal Sodium-Hydrogen Exchange in Healthy Subjects
por: Biancalana, Edoardo, et al.
Publicado: (2023)